Illumina (ILMN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

Illumina has been on fire lately. In the past six months alone, the company’s stock price has rocketed 47%, reaching $121.93 per share. This was partly due to its solid quarterly results, and the ...

Illumina, Inc. ILMN recently announced the launch of BioInsight, a new business unit developed to meet industry demand for deeper biologic insights, driven by the need of researchers and pharma ...

Illumina, Inc. ILMN recently announced the launch of Illumina Protein Prep, an assay designed to deliver superior performance for next-generation sequencing (NGS)-based proteomics discovery at scale.

Illumina, Inc. (NASDAQ:ILMN) reported better-than-expected earnings for the second quarter on Thursday. The company posted quarterly earnings of $1.19 per share which beat the analyst consensus ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

The stock's fall snapped a five-day winning streak.

The latest announcement is out from Illumina ( (ILMN) ).

Illumina (ILMN) delivered earnings and revenue surprises of +15.52% and +1.73%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?